U.S. scientists say they developed a squishy gel that when compressed -- like at a painful knee joint -- releases anti-inflammatory medicine. Xinqiao Jia, Chandran R. Sabanayagam and colleagues at the University of Delaware said in the ...
Tags: hydro gel, compresse, anti-inflammatory, Painful Joint, move
US-based medical device company Moximed has announced the successful completion of 500th worldwide implant of its KineSpring system, intended to provide a new treatment option for patients with mild-to-moderate knee osteoarthritis. The ...
Tags: Kinespring System, medical device
OligoMedic, a manufacturer of osteoarthritis products, has announced that it will launch its JointRep product, an injectable implant designed to treat cartilage articular joint defects and reduce articular pain. JointRep is a simple ...
Imprimis Pharmaceuticals has received approval from the Institutional Review Board (IRB) to initiate Phase III clinical trial protocol of its new topical non-steroidal anti-inflammatory drug (NSAID) candidate, Impracor. Impracor is based ...
Blue Belt, next generation surgical orthopedic instruments developer, has received 510(k) approval from the US Food and Drug Administration (FDA) to market its Stride Unicondylar Knee implant system. With the clearance, the Stride implant ...
Tags: Blue Belt, FDA Approval
Zimmer Holdings has introduced new injectable pain relief gel, Gel-One Hyaluronate, for knee arthritis patients who failed to respond to non-pharmacologic therapy, non-steroidal anti-inflammatory drugs or analgesics. The low-volume ...
Tags: pain relief, knee arthritis, treatment
Blue Belt Technologies has treated the first three US patients for unicondylar knee replacement (UKR), using its NavioPFS orthopedic surgical system. The UKR procedures, performed at the US-based Community Regional Medical Center, ...
Tags: Blue Belt Technologies, UKR, NavioPFS orthopedic surgical system
Cartiva, a developer of orthopedic implants, has completed enrolling patients in its MOTION trial. The prospective, multi-center trial, which has enrolled 233 patients across Canada and the UK, is designed to assess the company's ...
Tags: Cartiva, clinical trial, clinical technology
Moximed has implanted the first patient with its KineSpring system in a prospective, single-arm clinical US study. The study, named SOAR, will enroll 30 patien,,ts to evaluate the safety and efficacy of the medical spring system in the ...
Tags: Moximed, patient, KineSpring system
DJO Global has introduced OA Nano knee brace to reduce pain and enhance stability in patients with mild-to-moderate osteoarthritis. The new knee brace is manufactured using a new kind of metal that is as light as magnesium with the ...
Tags: DJO Global, OA Nano knee brace, reduce pain, enhance stability
Watson Laboratories, a subsidiary of Watson Pharmaceuticals, has won FDA abbreviated new drug application approval for Diclofenac Sodium and Misoprostol Delayed-Release Tablets. The company plans to launch Diclofenac Sodium and ...
Tags: Watson Laboratories
Active Implants in Delaware,US,has named Lex Giltaij as the company's new president and chief operating officer. Prior to joining the company,Giltaij held senior executive positions in Stryker Benelux and Stryker Biotech,where he was ...
Tags: active implants, Giltaij, treating pain, disability arising
Galapagos, a mid-size biotechnology company, has delivered the first pre-clinical candidate compound in its osteoarthritis alliance with Servier. Servier and Galapagos entered into an alliance in July 2010 to develop new oral medicines ...
Tags: Galapagos Identifies Drug, Galapagos, Servier, osteoarthritis
The United States Patent Office has issued a patent covering Nuvo Research's compositions and methods of using Pennsaid (diclofenac sodium topical solution) 2.0% w/w (Pennsaid 2% Patent), which will expire on 21 April 2028. Pennsaid is a ...
Eli Lilly and Company has met the United States Food and Drug Administration (FDA) requirements for pediatric exclusivity for Cymbalta (duloxetine HCl), which is available in 20-mg, 30-mg, and 60-mg capsules. As part of the approval, ...